MALDI-MSI Spatially Maps N-glycan Alterations to Histologically Distinct Pulmonary Pathologies Following Irradiation
Affiliations
Radiation-induced lung injury is a highly complex combination of pathological alterations that develop over time and severity of disease development is dose-dependent. Following exposures to lethal doses of irradiation, morbidity and mortality can occur due to a combination of edema, pneumonitis and fibrosis. Protein glycosylation has essential roles in a plethora of biological and immunological processes. Alterations in glycosylation profiles have been detected in diseases ranging from infection, inflammation and cancer. We utilized mass spectrometry imaging to spatially map N-glycans to distinct pathological alterations during the clinically latent period and at 180 days post-exposure to irradiation. Results identified alterations in a number of high mannose, hybrid and complex N-glycans that were localized to regions of mucus and alveolar-bronchiolar hyperplasia, proliferations of type 2 epithelial cells, accumulations of macrophages, edema and fibrosis. The glycosylation profiles indicate most alterations occur prior to the onset of clinical symptoms as a result of pathological manifestations. Alterations in five N-glycans were identified as a function of time post-exposure. Understanding the functional roles N-glycans play in the development of these pathologies, particularly in the accumulation of macrophages and their phenotype, may lead to new therapeutic avenues for the treatment of radiation-induced lung injury.
Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases.
Drzewicka K, Zaslona Z Front Immunol. 2024; 15:1328781.
PMID: 38550597 PMC: 10973144. DOI: 10.3389/fimmu.2024.1328781.
Cervical spinal cord injury leads to injury and altered metabolism in the lungs.
Huffman E, Dong B, Clarke H, Young L, Gentry M, Allison D Brain Commun. 2023; 5(2):fcad091.
PMID: 37065091 PMC: 10090796. DOI: 10.1093/braincomms/fcad091.
Velickovic D, Liao Y, Thibert S, Velickovic M, Anderton C, Voglmeir J Front Plant Sci. 2022; 13:869281.
PMID: 35651768 PMC: 9150855. DOI: 10.3389/fpls.2022.869281.
High sensitivity glycomics in biomedicine.
Lageveen-Kammeijer G, Kuster B, Reusch D, Wuhrer M Mass Spectrom Rev. 2021; 41(6):1014-1039.
PMID: 34494287 PMC: 9788051. DOI: 10.1002/mas.21730.
Applications and continued evolution of glycan imaging mass spectrometry.
McDowell C, Lu X, Mehta A, Angel P, Drake R Mass Spectrom Rev. 2021; 42(2):674-705.
PMID: 34392557 PMC: 8946722. DOI: 10.1002/mas.21725.